Trial Profile
An Observational Study on the Use of Glucophage XR® Therapy in the Management of Patients With Type 2 Diabetes
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2018
Price :
$35
*
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Merck KGaA
- 18 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 04 Oct 2012 Planned end date changed from 1 Jun 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 20 Jun 2011 Actual initiation date (Jun 2011) added as reported by ClinicalTrials.gov.